Epigral Ltd. (EPIGRAL) — Cash Flow Reinvestment Rate
Epigral Ltd. (EPIGRAL) has a Cash Flow Reinvestment Rate of 0.88x as of September 2025, reinvesting Rs2.36 Billion (capex Rs2.36 Billion ) from operating cash flow of Rs2.67 Billion. Check cash flow quality index of Epigral Ltd. to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Epigral Ltd. Cash Flow Reinvestment Rate (2015–2026)
Historical reinvestment intensity for Epigral Ltd. across 12 annual periods. Explore Epigral Ltd. (EPIGRAL) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Epigral Ltd. (2015–2026)
Year-by-year capital reinvestment analysis for Epigral Ltd.. For live market cap and broader valuation context, see Epigral Ltd. (EPIGRAL) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 1.09x | Rs4.21 Billion | Rs3.88 Billion | Rs3.94 Billion | ▲ +77.2% |
| 2025 | 0.61x | Rs2.70 Billion | Rs4.41 Billion | Rs1.95 Billion | ▼ -39.2% |
| 2024 | 1.01x | Rs4.01 Billion | Rs3.98 Billion | Rs3.98 Billion | ▲ +51.7% |
| 2023 | 0.67x | Rs4.16 Billion | Rs6.26 Billion | Rs4.16 Billion | ▼ -58.8% |
| 2022 | 1.61x | Rs4.58 Billion | Rs2.84 Billion | Rs4.56 Billion | ▲ +87.8% |
| 2021 | 0.86x | Rs1.97 Billion | Rs2.29 Billion | Rs1.97 Billion | ▼ -61.7% |
| 2020 | 2.24x | Rs3.69 Billion | Rs1.65 Billion | Rs3.69 Billion | ▲ +93.6% |
| 2019 | 1.16x | Rs3.03 Billion | Rs2.61 Billion | Rs3.03 Billion | ▲ +110.9% |
| 2018 | 0.55x | Rs1.23 Billion | Rs2.25 Billion | Rs1.23 Billion | ▲ +117.6% |
| 2017 | 0.25x | Rs349.30 Million | Rs1.38 Billion | Rs349.30 Million | ▼ -46.8% |
| 2016 | 0.47x | Rs585.42 Million | Rs1.23 Billion | Rs585.42 Million | ▲ +1443.4% |
| 2015 | 0.03x | Rs34.48 Million | Rs1.12 Billion | Rs34.48 Million | — |